These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31791173)

  • 21. Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1.
    Pancera M; McLellan JS; Wu X; Zhu J; Changela A; Schmidt SD; Yang Y; Zhou T; Phogat S; Mascola JR; Kwong PD
    J Virol; 2010 Aug; 84(16):8098-110. PubMed ID: 20538861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bispecific engineered antibody domains (nanoantibodies) that interact noncompetitively with an HIV-1 neutralizing epitope and FcRn.
    Gong R; Wang Y; Ying T; Dimitrov DS
    PLoS One; 2012; 7(8):e42288. PubMed ID: 22879932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8.
    Soto C; Ofek G; Joyce MG; Zhang B; McKee K; Longo NS; Yang Y; Huang J; Parks R; Eudailey J; Lloyd KE; Alam SM; Haynes BF; ; Mullikin JC; Connors M; Mascola JR; Shapiro L; Kwong PD
    PLoS One; 2016; 11(6):e0157409. PubMed ID: 27299673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of epitope position on neutralization by anti-human immunodeficiency virus monoclonal antibody 2F5.
    Ou W; Lu N; Yu SS; Silver J
    J Virol; 2006 Mar; 80(5):2539-47. PubMed ID: 16474160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Epitope Complexity Correlated with Antibody Affinity Maturation and a Novel Binding Mode Revealed by Structures of Rabbit Antibodies against the Third Variable Loop (V3) of HIV-1 gp120.
    Pan R; Qin Y; Banasik M; Lees W; Shepherd AJ; Cho MW; Kong XP
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hiding in plain sight: structure and sequence analysis reveals the importance of the antibody DE loop for antibody-antigen binding.
    Kelow SP; Adolf-Bryfogle J; Dunbrack RL
    MAbs; 2020; 12(1):1840005. PubMed ID: 33180672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation effects on cis/trans isomerization and the backbone conformation of serine-proline motifs: accelerated molecular dynamics analysis.
    Hamelberg D; Shen T; McCammon JA
    J Am Chem Soc; 2005 Feb; 127(6):1969-74. PubMed ID: 15701032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational analysis of the first observed non-proline cis-peptide bond occurring within the complementarity determining region (CDR) of an antibody.
    Bates PA; Dokurno P; Freemont PS; Sternberg MJ
    J Mol Biol; 1998 Dec; 284(3):549-55. PubMed ID: 9826497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection.
    Acharya P; Tolbert WD; Gohain N; Wu X; Yu L; Liu T; Huang W; Huang CC; Kwon YD; Louder RK; Luongo TS; McLellan JS; Pancera M; Yang Y; Zhang B; Flinko R; Foulke JS; Sajadi MM; Kamin-Lewis R; Robinson JE; Martin L; Kwong PD; Guan Y; DeVico AL; Lewis GK; Pazgier M
    J Virol; 2014 Nov; 88(21):12895-906. PubMed ID: 25165110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limited conformational flexibility in the paratope may be responsible for degenerate specificity of HIV epitope recognition.
    Bhowmick A; Salunke DM
    Int Immunol; 2013 Feb; 25(2):77-90. PubMed ID: 22968994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.
    Oakes V; Torralba J; Rujas E; Nieva JL; Domene C; Apellaniz B
    Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1259-1271. PubMed ID: 29477358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation.
    Alam SM; Liao HX; Dennison SM; Jaeger F; Parks R; Anasti K; Foulger A; Donathan M; Lucas J; Verkoczy L; Nicely N; Tomaras GD; Kelsoe G; Chen B; Kepler TB; Haynes BF
    J Virol; 2011 Nov; 85(22):11725-31. PubMed ID: 21917975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Contacts between MPER and the Anti-HIV-1 Broadly Neutralizing Antibody 4E10 Extend into the Core of the Membrane.
    Rujas E; Insausti S; García-Porras M; Sánchez-Eugenia R; Tsumoto K; Nieva JL; Caaveiro JM
    J Mol Biol; 2017 Apr; 429(8):1213-1226. PubMed ID: 28300601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24.
    Monaco-Malbet S; Berthet-Colominas C; Novelli A; Battaï N; Piga N; Cheynet V; Mallet F; Cusack S
    Structure; 2000 Oct; 8(10):1069-77. PubMed ID: 11080628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic study on the cis-trans isomerization of peptidyl-proline dipeptides.
    Thunecke F; Kálmán A; Kálmán F; Ma S; Rathore AS; Horváth C
    J Chromatogr A; 1996 Sep; 744(1-2):259-72. PubMed ID: 8843674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N+1 Engineering of an Aspartate Isomerization Hotspot in the Complementarity-Determining Region of a Monoclonal Antibody.
    Patel CN; Bauer SP; Davies J; Durbin JD; Shiyanova TL; Zhang K; Tang JX
    J Pharm Sci; 2016 Feb; 105(2):512-518. PubMed ID: 26869414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.
    Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ
    PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of the respective loops at complementarity determining region on the antigen-antibody recognition.
    Osajima T; Hoshino T
    Comput Biol Chem; 2016 Oct; 64():368-383. PubMed ID: 27591792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoreactivity and exceptional CDR plasticity (but not unusual polyspecificity) hinder elicitation of the anti-HIV antibody 4E10.
    Finton KA; Larimore K; Larman HB; Friend D; Correnti C; Rupert PB; Elledge SJ; Greenberg PD; Strong RK
    PLoS Pathog; 2013; 9(9):e1003639. PubMed ID: 24086134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
    Doria-Rose NA; Schramm CA; Gorman J; Moore PL; Bhiman JN; DeKosky BJ; Ernandes MJ; Georgiev IS; Kim HJ; Pancera M; Staupe RP; Altae-Tran HR; Bailer RT; Crooks ET; Cupo A; Druz A; Garrett NJ; Hoi KH; Kong R; Louder MK; Longo NS; McKee K; Nonyane M; O'Dell S; Roark RS; Rudicell RS; Schmidt SD; Sheward DJ; Soto C; Wibmer CK; Yang Y; Zhang Z; ; Mullikin JC; Binley JM; Sanders RW; Wilson IA; Moore JP; Ward AB; Georgiou G; Williamson C; Abdool Karim SS; Morris L; Kwong PD; Shapiro L; Mascola JR
    Nature; 2014 May; 509(7498):55-62. PubMed ID: 24590074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.